Although the loss of HER2 antigenicity in breast FFPE blocks caused by stored time has been previously reported, our study was the first to show that in the new terms of HER2-low breast cancer, the loss of HER2 expression can cause false-negativity of HER2-low detection in stored tissue. This evidence concerns the gene ERBB2 and breast carcinoma.